Cancer Treatment News and Research

RSS

Sexual side effects of cancer treatment discussed less frequently with female patients

A new study finds that sexual side effects of cancer treatment are discussed far less frequently with female patients than with male patients, even when the treatment directly affects sex organs.

24 Oct 2022

MTCH2 acts as a doorway for proteins into the mitochondrial membrane, study reveals

Mitochondria - the organelles responsible for energy production in human cells - were once free-living organisms that found their way into early eukaryotic cells over a billion years ago.

20 Oct 2022

Penn State researchers lay the foundation for precision fabrication of tumor models

Researchers at Penn State have successfully 3D bioprinted breast cancer tumors and treated them in a breakthrough study to better understand the disease that is one of the leading causes of mortality worldwide.

18 Oct 2022

Physical exercise improves cardiorespiratory fitness, alleviates adverse effects of cancer treatment

During chemotherapy, physical exercise intervention is safe, improves long-term cardiorespiratory fitness, and alleviates some of the adverse effects of cancer treatment, according to a study published in JACC: CardioOncology.

18 Oct 2022

BU researcher awarded $4.6 million U2C grant to develop innovative lung cancer biomarkers

Lung cancer screening by chest computed tomography (CT) can detect lung cancer earlier and make the disease less deadly; but even among nodules that are at intermediate risk, only a small minority are cancerous.

17 Oct 2022

Study determines how fibroblasts play a role in tumor's ability to generate anti-HER2 therapy resistance

A study led by researchers at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) has determined the role that fibroblasts, the cells that contribute to tissue formation, play in a tumor's ability to generate resistance to the most common biological treatment for HER2.

14 Oct 2022

Multi-center analysis shines light on invasive lobular carcinoma

A multi-center analysis of patients with invasive lobular carcinoma, or ILC - the second most common histological subtype of invasive breast cancer in the U.S. - showed that, despite its prevalence, ILC is detected later and has worse outcomes than the predominant subtype of invasive breast cancer, known as invasive ductal carcinoma (IDC), or no special type.

14 Oct 2022

Over £800 million to support improved healthcare delivery and breakthroughs in new treatments

Patients up and down the country are set to benefit from innovative new treatments and improved delivery of health and care services following significant funding to support ground-breaking experimental medicine research and advance the UK's response to patient safety challenges.

14 Oct 2022

Protoporphyrin IX delayed fluorescence imaging as a modality for hypoxia-based oncologic surgical guidance

In the surgical treatment of cancer, distinguishing between tumors and healthy tissues is critical. Fluorescent markers can help to do this, by enhancing the contrast of tumors during surgery.

11 Oct 2022

Exploring the possibilities of plasma-based therapies for cancer

Exploring the possibilities of atmospheric-pressure plasmas to develop and consolidate new medical therapies is the main objective of the PlasTHER network, an initiative funded by the European Union under the COST Actions.

11 Oct 2022

Moffitt's effort to increase minority accrual to cancer treatment trials gets a $3.7 million boost

Moffitt Cancer Center's efforts to increase minority accrual to cancer treatment trials got a boost from the National Cancer Institute's Connecting Underrepresented Populations to Clinical Trials U01 Grants Program.

6 Oct 2022

Medical debt sunk her credit. New changes from the credit reporting agencies won’t help.

After a year of chemo and radiation, doctors told Penelope “Penny” Wingard in 2014 that her breast cancer was in remission. She'd been praying for this good news.

6 Oct 2022

Discovery opens up new approaches to personalized treatment for small cell lung cancer

Small cell lung cancer is a particularly aggressive tumor, which has so far been treated with standardized measures.

6 Oct 2022

Northwestern Medicine scientists discover new gene target for aggressive lung cancer

Northwestern Medicine scientists have identified and described a new gene that is responsible for activating an aggressive subtype of small-cell lung cancer, the P subtype, for which there is no current effective treatment.

5 Oct 2022

Epigenetics drug used to treat blood cancers, rare sarcomas can halt bladder cancer growth

An epigenetics drug currently being used for the treatment of blood cancers and rare sarcomas can stop the growth of bladder cancer by activating the immune system, reports a new Northwestern Medicine study done in mice.

5 Oct 2022

Research shows higher risk of sexual problems among young women cancer survivors

Young women cancer survivors are at much higher risk of sexual problems including loss of libido and discomfort, according to research published in the peer-reviewed journal Acta Oncologica.

30 Sep 2022

Researchers to use $1 million grant for improving blood cancer diagnosis and treatment

Adelaide researchers will use a $1 million grant to improve the diagnosis and treatment of blood cancers, which kill 16 Australians every day.

28 Sep 2022

Giving immunotherapy before targeted therapy improves survival in patients with advanced melanoma

A clinical trial led by clinicians at Georgetown Lombardi Comprehensive Cancer Center showed a remarkable 20 percent advantage in the two-year overall survival rate for people with advanced melanoma who first received immunotherapy (72 percent survival rate) versus those who initially got targeted therapies (52 percent survival rate).

27 Sep 2022

Prevention of cardiovascular disease is important in cancer patients

With the increasing number of cancer survivors, the medical community is becoming increasingly aware of a hitherto less noticed health risk: cancer therapy-related cardiovascular disease.

26 Sep 2022

Cancer survival rate rises in the US

In a recent article by the American Association for Cancer Research (AACR), the researchers highlighted basic, translational, and clinical cancer research and cancer-related population sciences in the 12th edition of its annual Cancer Progress Report.

25 Sep 2022

Cancer Treatment News and Research

Sexual side effects of cancer treatment discussed less frequently with female patients

MTCH2 acts as a doorway for proteins into the mitochondrial membrane, study reveals

Penn State researchers lay the foundation for precision fabrication of tumor models

Physical exercise improves cardiorespiratory fitness, alleviates adverse effects of cancer treatment

BU researcher awarded $4.6 million U2C grant to develop innovative lung cancer biomarkers

Study determines how fibroblasts play a role in tumor's ability to generate anti-HER2 therapy resistance

Multi-center analysis shines light on invasive lobular carcinoma

Over £800 million to support improved healthcare delivery and breakthroughs in new treatments

Protoporphyrin IX delayed fluorescence imaging as a modality for hypoxia-based oncologic surgical guidance

Exploring the possibilities of plasma-based therapies for cancer

Moffitt's effort to increase minority accrual to cancer treatment trials gets a $3.7 million boost

Medical debt sunk her credit. New changes from the credit reporting agencies won’t help.

Discovery opens up new approaches to personalized treatment for small cell lung cancer

Northwestern Medicine scientists discover new gene target for aggressive lung cancer

Epigenetics drug used to treat blood cancers, rare sarcomas can halt bladder cancer growth

Research shows higher risk of sexual problems among young women cancer survivors

Researchers to use $1 million grant for improving blood cancer diagnosis and treatment

Giving immunotherapy before targeted therapy improves survival in patients with advanced melanoma

Prevention of cardiovascular disease is important in cancer patients

Cancer survival rate rises in the US

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News